What is the Purpose of this Study?
The purpose of the study is to assess the impact of an artificial intelligence (AI)-based risk communication feedback system to improve patient decision making and quality of physician risk communication during prostate cancer consultations. The study focuses on people who have been newly diagnosed with early-stage prostate cancer. The study will audio record the patient’s treatment consultation and use AI to extract key information and create patient-specific summaries to help patients make informed health decisions. The study will also provide feedback to physicians on their quality of risk communication to help them improve quality of counseling.
Eligibility
- (1) Physicians who typically counsel prostate cancer patients (Urology, Radiation Oncology, Medical Oncology)
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men with Clinically Localized Prostate Cancer